Reversing established sepsis in rats with human vasoactive hormone adrenomedullin and its binding protein

Molecular Medicine

Volumn 15, Issue 1-2, 2009, Pages 28-33

  Wu, Rongqian ^b   Higuchi, Shinya ^b   Dong, Weifeng ^b   Ji, Youxin ^b   Zhou, Mian ^b   Marini, Corrado P ^b   Ravikumar, Thanjavur S ^b   Wang, Ping ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN BINDING PROTEIN; ALBUMIN; AMINOTRANSFERASE; CYTOKINE; HORMONE BINDING PROTEIN; INTERLEUKIN 6; LACTIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ADM PROTEIN, HUMAN; ADRENOMEDULLIN BINDING PROTEIN 1, HUMAN; ADRENOMEDULLIN-BINDING PROTEIN 1, HUMAN; COMPLEMENT FACTOR H;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; BLOOD SAMPLING; CECUM; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME BLOOD LEVEL; GANGRENE; INTESTINE; INTESTINE MUCOSA; LIGATION; MACROMOLECULE; MALE; MEMBRANE PERMEABILITY; MESENTERY LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUNCTURE; RAT; SEPSIS; SURVIVAL; SURVIVAL RATE; TISSUE INJURY; ANIMAL; BLOOD; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ADRENOMEDULLIN; ANIMALS; COMPLEMENT FACTOR H; CYTOKINES; HUMANS; INTERLEUKIN-6; INTESTINAL MUCOSA; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 59649109857     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2008.00092     Document Type: Article

References (47)

1. Remick DG. (2007) Pathophysiology of sepsis. Am. J. Pathol. 170:1435-44.
2. Howell G, Tisherman SA. (2006) Management of sepsis. Surg. Clin. North Am. 86:1523-39.
3. Powers J, Jacobi J. (2006) Pharmacologic treatment related to severe sepsis. AACN. Adv. Crit. Care 17:423-32.
4. Jenkins I. (2006) Evidence-based sepsis therapy: a hospitalist perspective. J. Hosp. Med. 1:285-95.
5. Bernard GR, et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344:699-709.
6. Martin GS, Mannino DM, Eaton S, Moss M. (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348:1546-54.
7. Danai PA, Sinha S, Moss M, Haber MJ, Martin GS. (2007) Seasonal variation in the epidemiology of sepsis. Crit. Care Med. 35:410-5.
8. Strehlow MC, Emond SD, Shapiro NI, Pelletier AJ, Camargo CA Jr. (2006) National study of emergency department visits for sepsis, 1992 to 2001. Ann. Emerg. Med. 48:326-31.
9. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29:1303-10.
10. Kitamura K, et al. (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192:553-60.
11. Elsasser TH, et al. (1999) Adrenomedullin binding protein in the plasma of multiple species: characterization by radioligand blotting. Endocrinology 140:4908-11.
12. Pio R, et al. (2001) Complement factor H is a serum binding protein for adrenomedullin. The resulting complex modulates the bioactivities of both partners. J. Biol. Chem. 276:12292-300.
13. Zhou M, Ba ZF, Chaudry IH, Wang P. (2002) Adrenomedullin binding protein-1 modulates vascular responsiveness to adrenomedullin in late sepsis. Am. J. Physiol Regul. Integr. Comp. Physiol. 283:R553-60.
14. Yang S, Zhou M, Chaudry IH, Wang P. (2002) Novel approach to prevent the transition from the hyperdynamic phase to the hypodynamic phase of sepsis: role of adrenomedullin and adrenomedullin binding protein-1. Ann. Surg. 236:625-33.
15. Yang S, Zhou M, Fowler DE, Wang P. (2002) Mechanisms of the beneficial effect of adrenomedullin and adrenomedullin-binding protein-1 in sepsis: down-regulation of proinflammatory cytokines. Crit. Care Med. 30:2729-35.
16. Dogan A, et al. (1997) Intravenous infusion of adrenomedullin and increase in regional cerebral blood flow and prevention of ischemic brain injury after middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 17:19-25.
17. Wu R, et al. (2007) Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. Am. J. Respir. Crit. Care Med. 176:805-13.
18. Cui X, Wu R, Zhou M, Simms HH, Wang P. (2004) Differential expression of cytochrome P450 isoforms in the lungs of septic animals. Crit. Care Med. 32:1186-91.
19. Wu R, et al. (2007) Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann. Surg. 245:480-6.
20. Fink MP. (1994) Effect of critical illness on microbial translocation and gastrointestinal mucosa permeability. Semin. Respir. Infect. 9:256-60.
21. Chavez AM, Menconi MJ, Hodin RA, Fink MP. (1999) Cytokine-induced intestinal epithelial hyperpermeability: role of nitric oxide. Crit Care Med. 27:2246-51.
22. Yang R, et al. (2003) IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am J. Physiol. Gastrointest. Liver Physiol. 285:G621-29.
23. Yang R, et al. (2006) Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Mol. Med. 12:105-14.
24. Wu R, et al. (2008) Orexigenic hormone ghrelin attenuates local and remote organ injury after intestinal ischemia-reperfusion. PLoS. ONE. 3:e2026.
25. Kitamura K, et al. (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192:553-60.
26. Samson WK. (1999) Adrenomedullin and the control of fluid and electrolyte homeostasis. Annu. Rev. Physiol. 61:363-89.
27. Isumi Y, Kubo A, Katafuchi T, Kangawa K, Minamino N. (1999) Adrenomedullin suppresses interleukin-1β-induced tumor necrosis factor-α production in Swiss 3T3 cells. FEBS Lett. 463:110-4.
28. Kubo A, et al. (1998) Production of adrenomedullin in macrophage cell line and peritoneal macrophage. J. Biol. Chem. 273:16730-8.
29. Dackor R, Caron K. (2007) Mice heterozygous for adrenomedullin exhibit a more extreme inflammatory response to endotoxin-induced septic shock. Peptides 28:2164-70.
30. Ueda S, et al. (1999) Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome. Am. J. Respir. Crit Care Med. 160:132-6.
31. Nishio K, et al. (1997) Increased plasma concentrations of adrenomedullin correlate with relaxation of vascular tone in patients with septic shock. Crit. Care Med. 25:953-7.
32. Wang P, Zhou M, Ba ZF, Cioffi WG, Chaudry IH. (1998) Up-regulation of a novel potent vasodilatory peptide adrenomedullin during polymicrobial sepsis. Shock 10:118-22.
33. Fowler DE, et al. (2003) Adrenomedullin and adrenomedullin binding protein-1: their role in the septic response. J. Surg Res. 109:175-81.
34. Demberg T, Pollok-Kopp B, Gerke D, Gotze O, Schlaf G. (2002) Rat complement factor H: molecular cloning, sequencing and quantification with a newly established ELISA. Scand. J. Immunol. 56:149-60.
35. Beltowski J, Jamroz A. (2004) Adrenomedullin: what we know 10 years since its discovery? Pol. J. Pharmacol. 56:5-27.
36. Wu R, Zhou M, Wang P. (2003) Adrenomedullin and adrenomedullin binding protein-1 downregulate TNF-alpha in macrophage cell line and rat Kupffer cells. Regul. Pept. 112:19-26.
37. Miksa M, et al. (2007) Vasoactive hormone adrenomedullin and its binding protein: antiinflammatory effects by up-regulating peroxisome proliferator-activated receptor-gamma. J. Immunol. 179:6263-72.
38. Naked GM, et al. (2000) Deficiency of human complement factor I associated with lowered factor H. Clin. Immunol. 96:162-7.
39. Cui Y, Ji Y, Wu R, Zhou M, Wang P. (2006) Adrenomedullin binding protein-1 is downregulated during polymicrobial sepsis in the rat. Int. J. Mol. Med. 17:925-9.
40. Friese MA, et al. (1999) FHL-1/reconectin and factor H: two human complement regulators which are encoded by the same gene are differently expressed and regulated. Mol. Immunol. 36:809-18.
41. Schwaeble W, et al. (1987) Human complement factor H: expression of an additional truncated gene product of 43 kDa in human liver. Eur. J. Immunol. 17:1485-9.
42. Luo W, Vik DP. (1999) Regulation of complement factor H in a human liver cell line by interferon-gamma. Scand. J. Immunol. 49:487-94.
43. Haas PJ, van Strijp J. (2007) Anaphylatoxins: their role in bacterial infection and inflammation. Immunol. Res. 37:161-75.
44. Hoesel LM, Gao H, Ward PA. (2006) New insights into cellular mechanisms during sepsis. Immunol. Res. 34:133-41.
45. Hoesel LM, Niederbichler AD, Ward PA. (2007) Complement-related molecular events in sepsis leading to heart failure. Mol. Immunol. 44:95-102.
46. Sakata J, et al. (1993) Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem. Biophys. Res. Commun. 195:921-7.
47. Wu R, et al. (2008) Human vasoactive hormone adrenomedullin and its binding protein rescue experimental animals from shock. Peptides 29:1223-30.